Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium lactate pentahydrate is a calcium salt of lactic acid, specifically the pentahydrate form, utilized primarily as a mineral supplement to treat or prevent calcium deficiency (hypocalcemia). As a small molecule pharmaceutical, it serves as a source of calcium ions ($Ca^{2+}$), which are vital for maintaining bone integrity, facilitating neurotransmission, supporting muscle contraction, and enabling blood coagulation. Developed and manufactured by Remedica, it is typically administered orally and is indicated for conditions where dietary calcium intake is insufficient or where physiological demands for calcium are increased, such as osteoporosis or during pregnancy and lactation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium lactate pentahydrate.